Chemical Compound Review:
Butacote 4-butyl-1,2-diphenyl- pyrazolidine-3,5-dione
Synonyms:
Anpuzone, Artrizin, Butadion, Butapirazol, Butazolidin, ...
- Aplastic anemia from veterinary phenylbutazone. Ramsey, R., Golde, D.W. JAMA (1976)
- Agranulocytosis caused by Chinese herbal medicines. Dangers of medications containing aminopyrine and phenylbutazone. Ries, C.A., Sahud, M.A. JAMA (1975)
- Antibody-dependent killing of tumor cells by polymorphonuclear leukocytes. Involvement of oxidative and nonoxidative mechanisms. Dallegri, F., Patrone, F., Frumento, G., Sacchetti, C. J. Natl. Cancer Inst. (1984)
- Phenylbutazone liver injury: a clinical-pathologic survey of 23 cases and review of the literature. Benjamin, S.B., Ishak, K.G., Zimmerman, H.J., Grushka, A. Hepatology (1981)
- Double-blind study of fenoprofen versus phenylbutazone in acute gouty arthritis. Weiner, G.I., White, S.R., Weitzner, R.I., Rubinstein, H.M. Arthritis Rheum. (1979)
- Differential effects of phenylbutazone and local anesthetics on nociception in the equine. Kamerling, S.G., Dequick, D.J., Weckman, T.J., Sprinkle, F.P., Tobin, T. Eur. J. Pharmacol. (1984)
- Renal papillary necrosis in horses after phenylbutazone and water deprivation. Gunson, D.E., Soma, L.R. Vet. Pathol. (1983)
- Biochemical and haematological effects of phenylbutazone in horses. Lees, P., Creed, R.F., Gerring, E.E., Gould, P.W., Humphreys, D.J., Maitho, T.E., Michell, A.R., Taylor, J.B. Equine Vet. J. (1983)
- Crystal-induced neutrophil activation. IV. Specific inhibition of tyrosine phosphorylation by colchicine. Roberge, C.J., Gaudry, M., de Médicis, R., Lussier, A., Poubelle, P.E., Naccache, P.H. J. Clin. Invest. (1993)
- Long-term studies on carcinogenicity and promoting effect of phenylbutazone in DONRYU rats. Meakawa, A., Onodera, H., Tanigawa, H., Furuta, K., Kanno, J., Matsuoka, C., Ogiu, T., Hayashi, Y. J. Natl. Cancer Inst. (1987)
- Chemotactic deactivation of human neutrophils: protective influence of phenylbutazone. Nelson, R.D., Gracyk, J.M., Fiegel, V.D., Herron, M.J., Chenoweth, D.E. Blood (1981)
- Genetic control of interindividual variations in the inducibility of aryl hydrocarbon hydroxylase in cultured human lymphocytes. Atlas, S.A., Vesell, E.S., Nebert, D.W. Cancer Res. (1976)
- Mechanism of action of colchicine. III. Antiinflammatory effects of colchicine compared with phenylbutazone and indomethacin. Chang, Y.H. Arthritis Rheum. (1975)
- Mianserin and agranulocytosis in New Zealand. Coulter, D.M., Edwards, I.R. Lancet (1990)
- Aroyl- and arylisoquinolineacetic acids as antiinflammatory agents. Walsh, D.A., Sancilio, L.F., Reese, D.L. J. Med. Chem. (1978)
- Sulphasalazine and PhCL28A inhibit the formation of ethanol- and phenylbutazone-induced rat gastric ulcers: lack of involvement of endogenous prostaglandins? Berry, C.N., Prouteau, M., Lloyd, K.G. Br. J. Pharmacol. (1988)
- Generalized pustular psoriasis precipitated by phenylbutazone and oxyphenbutazone. Reshad, H., Hargreaves, G.K., Vickers, C.F. Br. J. Dermatol. (1983)
- Interactions of analgesics with other drugs. Klotz, U. Am. J. Med. (1983)
- The effect of malnutrition on the pharmacokinetics of phenylbutazone. Krishnaswamy, K., Ushasri, V., Naidu, N.A. Clinical pharmacokinetics. (1981)
- Influence of dietary protein on the anti-inflammatory and ulcerogenic effects and on the pharmacokinetics of phenylbutazone in rats. Varma, D.R. J. Pharmacol. Exp. Ther. (1979)
- The effect of anti-inflammatory agents and inflammation on granulocyte adherence. Evidence for regulation by plasma factors. MacGregor, R.R. Am. J. Med. (1976)
- Prostaglandin hydroperoxidase-dependent oxidation of phenylbutazone: relationship to inhibition of prostaglandin cyclooxygenase. Hughes, M.F., Mason, R.P., Eling, T.E. Mol. Pharmacol. (1988)
- Enhanced susceptibility of Escherichia coli to intracellular killing by human polymorphonuclear leukocytes after in vitro incubation with chloramphenicol. Pruul, H., Wetherall, B.L., McDonald, P.J. Antimicrob. Agents Chemother. (1981)
- Cytotoxicity of human peripheral blood and colostral leukocytes against Shigella species. Morgan, D.R., DuPont, H.L., Gonik, B., Kohl, S. Infect. Immun. (1984)
- Involvement of leukocytes in the oxygenation and chlorination reaction of phenylbutazone. Ichihara, S., Tomisawa, H., Fukazawa, H., Tateishi, M., Joly, R., Heintz, R. Biochem. Pharmacol. (1986)
- Flurbiprofen in the treatment of ankylosing spondylitis. A comparison with phenylbutazone. Lomen, P.L., Turner, L.F., Lamborn, K.R., Brinn, E.L., Sattler, L.P. Am. J. Med. (1986)
- Effect of oral contraceptives on plasma clearance. Carter, D.E., Bressler, R., Hughes, M.R., Haussler, M.R., Christian, D., Heine, M.W. Clin. Pharmacol. Ther. (1975)
- Increased adhesiveness of complement-stimulated neonatal calf neutrophils and its pharmacologic inhibition. Zwahlen, R.D., Slauson, D.O., Neilsen, N.R., Clifford, C.B. J. Leukoc. Biol. (1987)
- Multicentre trial of naproxen and phenylbutazone in acute gout. Sturge, R.A., Scott, J.T., Hamilton, E.B., Liyanage, S.P., Dixon, A.S., Davies, J., Engler, C. Ann. Rheum. Dis. (1977)
- Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. Laneuville, O., Breuer, D.K., Dewitt, D.L., Hla, T., Funk, C.D., Smith, W.L. J. Pharmacol. Exp. Ther. (1994)
- Evaluation of the ability of carprofen and flunixin meglumine to inhibit activation of nuclear factor kappa B. Bryant, C.E., Farnfield, B.A., Janicke, H.J. Am. J. Vet. Res. (2003)
- European experience with flurbiprofen. A new analgesic/anti-inflammatory agent. Buchanan, W.W., Kassam, Y.B. Am. J. Med. (1986)
- Characterization of methotrexate transport and its drug interactions with human organic anion transporters. Takeda, M., Khamdang, S., Narikawa, S., Kimura, H., Hosoyamada, M., Cha, S.H., Sekine, T., Endou, H. J. Pharmacol. Exp. Ther. (2002)
- Promotion of oxidative damage to arachidonic acid and alpha 1-antiproteinase by anti-inflammatory drugs in the presence of the haem proteins myoglobin and cytochrome C. Evans, P.J., Akanmu, D., Halliwell, B. Biochem. Pharmacol. (1994)
- Hemoperfusion for phenylbutazone poisoning. Berlinger, W.G., Spector, R., Flanigan, M.J., Johnson, G.F., Groh, M.R. Ann. Intern. Med. (1982)
- Phenylbutazone-induced systemic vasculitis with crescentic glomerulonephritis. Leung, A.C., McLay, A., Dobbie, J.W., Jones, J.M. Arch. Intern. Med. (1985)
- Clinical pharmacokinetics of phenylbutazone. Aarbakke, J. Clinical pharmacokinetics. (1978)
- Effects of various prostaglandin synthesis inhibitors on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine. Takahashi, M., Furukawa, F., Toyoda, K., Sato, H., Hasegawa, R., Imaida, K., Hayashi, Y. Carcinogenesis (1990)
- Double-blind trial of naproxen and phenylbutazone in ankylosing spondylitis. Van Gerwen, F., Van der Korst, J.K., Gribnau, F.W. Ann. Rheum. Dis. (1978)